Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Fujisawa pursues new indications for tacrolimus

Oct. 11, 1996

Successful reversal of acute kidney graft rejection with Thymoglobulin

Oct. 11, 1996

BioTransplant's transplant technologies covered by four new patents

Oct. 11, 1996

Evidence indicates wider application of VasoCare therapy

Oct. 11, 1996

Cytel-Baxter xenotransplantation collaboration

Oct. 11, 1996

First recombinant DTaP vaccine submitted for FDA approval

Oct. 11, 1996

SangStat's ciclosporin bioequivalent to Sandoz drug

Oct. 11, 1996

Cel-Sci forms collaboration for development of herpesvirus vaccine

Oct. 11, 1996

Protein Design Labs' humanized antibody effective in reducing kidney transplant rejection

Oct. 4, 1996

First approval for a DTaP-IPV vaccine

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...